These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38030989

  • 1. Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.
    Wang F, Cui S, Lu L, Shao X, Yan F, Liu Y, He B, Wang J, Cao Y, Yue Y, Wang Y, Gu W.
    BMC Cancer; 2023 Nov 29; 23(1):1165. PubMed ID: 38030989
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†.
    Cottereau AS, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I.
    Ann Oncol; 2021 Mar 29; 32(3):404-411. PubMed ID: 33278600
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.
    Shagera QA, Cheon GJ, Koh Y, Yoo MY, Kang KW, Lee DS, Kim EE, Yoon SS, Chung JK.
    Eur J Nucl Med Mol Imaging; 2019 Jul 29; 46(7):1417-1427. PubMed ID: 30941463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma.
    Wu W, Zhao L, Wang Y, Chen P, Yuan X, Miao L, Zhu Y, Mao J, Cai Z, Ji Y, Wang L, Jia T.
    Curr Probl Cancer; 2024 Feb 29; 48():101066. PubMed ID: 38364336
    [Abstract] [Full Text] [Related]

  • 10. FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma.
    Jo JH, Chung HW, Kim SY, Lee MH, So Y.
    Nucl Med Mol Imaging; 2023 Feb 29; 57(1):26-33. PubMed ID: 36643943
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT.
    Delaby G, Hubaut MA, Morschhauser F, Besson A, Huglo D, Herbaux C, Baillet C.
    Leuk Lymphoma; 2020 Jul 29; 61(7):1584-1591. PubMed ID: 32100597
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY, Guo Z, Sun J, Yang WP, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic significance of (18)F-fluorodeoxyglucose positron emission tomography in patients with diffuse large B cell lymphoma undergoing autologous stem cell transplantation].
    Ying ZT, Mi L, Wang XJ, Zhang YW, Yang Z, Song YQ, Wang XP, Zheng W, Lin NJ, Tu MF, Xie Y, Ping LY, Zhang C, Liu WP, Deng LJ, Zhu J.
    Zhonghua Xue Ye Xue Za Zhi; 2018 May 14; 39(5):382-386. PubMed ID: 29779346
    [Abstract] [Full Text] [Related]

  • 14. Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment.
    Jin H, Jin M, Lim CH, Choi JY, Kim SJ, Lee KH.
    Front Oncol; 2023 May 14; 13():1186311. PubMed ID: 37384292
    [Abstract] [Full Text] [Related]

  • 15. [Values of Different Evaluation Criteria of Interim 18F-FDG PET/CT Scan for Prediction of Prognosis in Patients with DLBCL].
    Zhu LT, Cen XN, Ou JP, Qiu ZX, Wang LH, Liu W, Wang WS, Dong YJ, Liang ZY, Wang MJ, Xu WL, Sun YH, Wang Q, Yin Y, Ren HY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr 14; 25(2):431-437. PubMed ID: 28446288
    [Abstract] [Full Text] [Related]

  • 16. Value of 18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen.
    Jiang C, Teng Y, Chen J, Wang Z, Zhou Z, Ding C, Xu J.
    Ann Nucl Med; 2020 Dec 14; 34(12):911-919. PubMed ID: 33057996
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L, Wang X, Wang CY, Xia B, Ning QY, Yang HL, Yu Y, Zhang YZ.
    Zhonghua Yi Xue Za Zhi; 2019 Jun 25; 99(24):1853-1858. PubMed ID: 31269579
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of baseline 18F-FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B-cell lymphoma receiving R-CHOP chemotherapy.
    Zhu L, Meng Y, Guo L, Zhao H, Shi Y, Li S, Wang A, Zhang X, Shi J, Zhu J, Xu K.
    Oncol Lett; 2021 Feb 25; 21(2):132. PubMed ID: 33552253
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL).
    Xie Y, Teng Y, Jiang C, Ding C, Zhou Z.
    Jpn J Radiol; 2023 Jul 25; 41(7):777-786. PubMed ID: 36752954
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.